Inactivation of the Mouse Huntington's Disease Gene Homolog Hdh
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Huntington's disease (HD) is a dominant neurodegenerative disorder caused by expansion of a CAG repeat in the gene encoding huntingtin, a protein of unknown function. To distinguish between "loss of function" and "gain of function" models of HD, the murine HD homolog Hdh was inactivated by gene targeting. Mice heterozygous for Hdh inactivation were phenotypically normal, whereas homozygosity resulted in embryonic death. Homozygotes displayed abnormal gastrulation at embryonic day 7.5 and were resorbing by day 8.5. Thus, huntingtin is critical early in embryonic development, before the emergence of the nervous system. That Hdh inactivation does not mimic adult HD neuropathology suggests that the human disease involves a gain of function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similar to α-syn in PD and Tau in AD, polyQ-HTT aggregates exert toxic gain-of-function effects, forming β-sheet-rich structures that disrupt essential cellular pathways and cause neurotoxicity [169,170].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [169]
In the citing paper
“Similar to α-syn in PD and Tau in AD, polyQ-HTT aggregates exert toxic gain-of-function effects, forming β-sheet-rich structures that disrupt essential cellular pathways and cause neurotoxicity [169,170].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [169]
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Self-citationVerkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481
Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.
Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W., & Roder, J. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8424 · Cited by 2,329
Neuropathological Classification of Huntingtonʼs Disease
VONSATTEL, J.-P., MYERS, R. H., STEVENS, T. J., FERRANTE, R. J., BIRD, E. D., & RICHARDSON, E. P. (1985) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198511000-00003 · Cited by 2,227
Self-citationAbsence of expression of the FMR-1 gene in fragile X syndrome
Pieretti, M., Zhang, F., Fu, Y.-H., Warren, S. T., Oostra, B. A., Caskey, C. T., & Nelson, D. L. (1991) · Cell · doi:10.1016/0092-8674(91)90125-i · Cited by 1,476
Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene
Tybulewicz, V. L. J., Crawford, C. E., Jackson, P. K., Bronson, R. T., & Mulligan, R. C. (1991) · Cell · doi:10.1016/0092-8674(91)90011-m · Cited by 1,281
Fmr1 knockout mice: A model to study fragile X mental retardation
THEDUTCHBELGIANFRAGILEXCONSOR (1994) · Cell · doi:10.1016/0092-8674(94)90569-x · Cited by 1,035
Nasir, J., Floresco, S. B., O'Kusky, J. R., Diewert, V. M., Richman, J. M., Zeisler, J., Borowski, A., Marth, J. D., Phillips, A. G., & Hayden, M. R. (1995) · Cell · doi:10.1016/0092-8674(95)90542-1 · Cited by 872
Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons
DiFiglia, M., Sapp, E., Chase, K., Schwarz, C., Meloni, A., Young, C., Martin, E., Vonsattel, J.-P., Carraway, R., Reeves, S. A., et al. (1995) · Neuron · doi:10.1016/0896-6273(95)90346-1 · Cited by 749
Self-citationDNA methylation represses FMR-1 transcription in fragile X syndrome
Sutcliffe, J. S., Nelson, D. L., Zhang, F., Pieretti, M., Caskey, C. T., Saxe, D., & Warren, S. T. (1992) · Human Molecular Genetics · doi:10.1093/hmg/1.6.397 · Cited by 680
Research works printed but not linked: 3
- CELL 78: 23 (1994).
- Nagy, A., Gene Targeting: A Practical Approach: 147 (1993).
- Wurst, W., Gene Targeting: A Practical Approach: 31 (1993).
Cited by
Items 101–200 of 885
Deletion of the Huntingtin Polyglutamine Stretch Enhances Neuronal Autophagy and Longevity in Mice
Zheng, S., Clabough, E. B. D., Sarkar, S., Futter, M., Rubinsztein, D. C., & Zeitlin, S. O. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000838 · Cited by 183
Genetic modifiers of Huntington's disease
Gusella, J. F., MacDonald, M. E., & Lee, J. (2014) · Movement Disorders · doi:10.1002/mds.26001 · Cited by 150
Self-citationSubtype‐Specific Enhancement of NMDA Receptor Currents by Mutant Huntingtin
Chen, N., Luo, T., Wellington, C., Metzler, M., McCutcheon, K., Hayden, M. R., & Raymond, L. A. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0721890.x · Cited by 180
Distinct roles for visceral endoderm during embryonic mouse development
Bielinska, M., Narita, N., & Wilson, D. B. (1999) · The International Journal of Developmental Biology · doi:10.1387/ijdb.10410899 · Cited by 180
The selective vulnerability of nerve cells in Huntington's disease
Sieradzan, K. A., & Mann, D. M. A. (2001) · Neuropathology and Applied Neurobiology · doi:10.1046/j.0305-1846.2001.00299.x · Cited by 180
Karlin, S., & Burge, C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1560 · Cited by 179
Wang, J., Gines, S., MacDonald, M. E., & Gusella, J. F. (2005) · BMC Neuroscience · doi:10.1186/1471-2202-6-1 · Cited by 179
Self-citationBao, J., Sharp, A. H., Wagster, M. V., Becher, M., Schilling, G., Ross, C. A., Dawson, V. L., & Dawson, T. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.5037 · Cited by 157
Recent Advances on the Pathogenesis of Huntington's Disease
Petersén, Å., Mani, K., & Brundin, P. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.7006 · Cited by 178
Knock-in mouse models of Huntington’s disease
Menalled, L. (2005) · NeuroRx · doi:10.1602/neurorx.2.3.465 · Cited by 178
Huntingtin's Neuroprotective Activity Occurs via Inhibition of Procaspase-9 Processing
Rigamonti, D., Sipione, S., Goffredo, D., Zuccato, C., Fossale, E., & Cattaneo, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100044200 · Cited by 174
Van Raamsdonk, J. M., Pearson, J., Rogers, D. A., Bissada, N., Vogl, A. W., Hayden, M. R., & Leavitt, B. R. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi147 · Cited by 173
Hebb, A. L. O., Robertson, H. A., & Denovan-Wright, E. M. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.11.009 · Cited by 172
Emerging degrader technologies engaging lysosomal pathways
Ding, Y., Xing, D., Fei, Y., & Lu, B. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00624c · Cited by 170
Huntingtin Is Required for Normal Excitatory Synapse Development in Cortical and Striatal Circuits
McKinstry, S. U., Karadeniz, Y. B., Worthington, A. K., Hayrapetyan, V. Y., Ozlu, M. I., Serafin-Molina, K., Risher, W. C., Ustunkaya, T., Dragatsis, I., Zeitlin, S., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.4699-13.2014 · Cited by 152
Evers, M. M., Miniarikova, J., Juhas, S., Vallès, A., Bohuslavova, B., Juhasova, J., Skalnikova, H. K., Vodicka, P., Valekova, I., Brouwers, C., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.06.021 · Cited by 168
Faulty neuronal determination and cell polarization are reverted by modulating HD early phenotypes
Conforti, P., Besusso, D., Bocchi, V. D., Faedo, A., Cesana, E., Rossetti, G., Ranzani, V., Svendsen, C. N., Thompson, L. M., Toselli, M., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1715865115 · Cited by 168
Huntington's disease: molecular basis of neurodegeneration
Rubinsztein, D. C., & Carmichael, J. (2003) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399403006549 · Cited by 151
Vaz, R. L., Outeiro, T. F., & Ferreira, J. J. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00347 · Cited by 166
Wild-Type Huntingtin Plays a Role in Brain Development and Neuronal Survival
Reiner, A., Dragatsis, I., Zeitlin, S., & Goldowitz, D. (2003) · Molecular Neurobiology · doi:10.1385/mn:28:3:259 · Cited by 165
The Role of Cathepsin D in the Pathogenesis of Human Neurodegenerative Disorders
Vidoni, C., Follo, C., Savino, M., Melone, M. A. B., & Isidoro, C. (2016) · Medicinal Research Reviews · doi:10.1002/med.21394 · Cited by 164
Selective Neuronal Degeneration in Huntington's Disease
(2006) · Current Topics in Developmental Biology · doi:10.1016/s0070-2153(06)75002-5 · Cited by 163
Therapeutic approaches to Huntington disease: from the bench to the clinic
Caron, N. S., Dorsey, E. R., & Hayden, M. R. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.133 · Cited by 162
Ferrante, R. J., Gutekunst, C.-A., Persichetti, F., McNeil, S. M., Kowall, N. W., Gusella, J. F., MacDonald, M. E., Beal, M. F., & Hersch, S. M. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-09-03052.1997 · Cited by 161
Self-citationShaping the role of mitochondria in the pathogenesis of Huntington's disease
Costa, V., & Scorrano, L. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.65 · Cited by 161
Enhanced Sensitivity of Striatal Neurons to Axonal Transport Defects Induced by Mutant Huntingtin
Her, L.-S., & Goldstein, L. S. B. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4144-08.2008 · Cited by 138
Dragatsis, I., Efstratiadis, A., & Zeitlin, S. (1998) · Development · doi:10.1242/dev.125.8.1529 · Cited by 131
Ekman, F. K., Ojala, D. S., Adil, M. M., Lopez, P. A., Schaffer, D. V., & Gaj, T. (2019) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2019.07.009 · Cited by 159
Antioxidants in Huntington's disease
Johri, A., & Beal, M. F. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.11.014 · Cited by 159
A molecular investigation of true dominance in Huntington’s disease
Narain, Y., Wyttenbach, A., Rankin, J., Furlong, R. A., & Rubinsztein, D. C. (1999) · Journal of Medical Genetics · doi:10.1136/jmg.36.10.739 · Cited by 158
Sequence Information from 42−108-mer DNAs (Complete for a 50-mer) by Tandem Mass Spectrometry
Little, D. P., Aaserud, D. J., Valaskovic, G. A., & McLafferty, F. W. (1996) · Journal of the American Chemical Society · doi:10.1021/ja9533611 · Cited by 157
Huntingtin-deficient zebrafish exhibit defects in iron utilization and development
Lumsden, A. L., Henshall, T. L., Dayan, S., Lardelli, M. T., & Richards, R. I. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm138 · Cited by 156
Huntingtin inhibits caspase‐3 activation
Zhang, Y., Leavitt, B. R., Raamsdonk, J. M. V., Dragatsis, I., Goldowitz, D., MacDonald, M. E., Hayden, M. R., & Friedlander, R. M. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601445 · Cited by 156
Self-citationHuntington’s Disease: Complex Pathogenesis and Therapeutic Strategies
Tong, H., Yang, T., Xu, S., Li, X., Liu, L., Zhou, G., Yang, S., Yin, S., Li, X., & Li, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073845 · Cited by 157
Proteins Containing Expanded Polyglutamine Tracts and Neurodegenerative Disease
Adegbuyiro, A., Sedighi, F., Pilkington, A. W., Groover, S. E., & Legleiter, J. A. (2017) · Biochemistry · doi:10.1021/acs.biochem.6b00936 · Cited by 154
Koshy, B. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.9.1311 · Cited by 145
Six-month partial suppression of Huntingtin is well tolerated in the adult rhesus striatum
Grondin, R., Kaytor, M. D., Ai, Y., Nelson, P. T., Thakker, D. R., Heisel, J., Weatherspoon, M. R., Blum, J. L., Burright, E. N., Zhang, Z., et al. (2012) · Brain · doi:10.1093/brain/awr333 · Cited by 153
Gagnon, K. T., Pendergraff, H. M., Deleavey, G. F., Swayze, E. E., Potier, P., Randolph, J., Roesch, E. B., Chattopadhyaya, J., Damha, M. J., Bennett, C. F., et al. (2010) · Biochemistry · doi:10.1021/bi101208k · Cited by 139
Neurobiology of Huntington's Disease
Sharp, A. H., & Ross, C. A. (1996) · Neurobiology of Disease · doi:10.1006/nbdi.1996.0002 · Cited by 137
Wang, G., Liu, X., Gaertig, M. A., Li, S., & Li, X.-J. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1524575113 · Cited by 146
Depletion of wild‐type huntingtin in mouse models of neurologic diseases
Zhang, Y., Li, M., Drozda, M., Chen, M., Ren, S., Mejia Sanchez, R. O., Leavitt, B. R., Cattaneo, E., Ferrante, R. J., Hayden, M. R., et al. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01980.x · Cited by 120
Sardo, V. L., Zuccato, C., Gaudenzi, G., Vitali, B., Ramos, C., Tartari, M., Myre, M. A., Walker, J. A., Pistocchi, A., Conti, L., et al. (2012) · Nature Neuroscience · doi:10.1038/nn.3080 · Cited by 145
Self-citationAuerbach, W. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.22.2515 · Cited by 125
Self-citationStriatal Transplantation in a Transgenic Mouse Model of Huntington's Disease
Dunnett, S. B., Carter, R. J., Watts, C., Torres, E. M., Mahal, A., Mangiarini, L., Bates, G. P., & Morton, A. J. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6926 · Cited by 144
The Neuropathology of CAG Repeat Diseases: Review and Update of Genetic and Molecular Features
Robitaille, Y., Lopes‐Cendes, Í., Bêcher, M. W., Rouleau, G. A., & Clark, A. W. (1997) · Brain Pathology · doi:10.1111/j.1750-3639.1997.tb00893.x · Cited by 143
Southwell, A. L., Khoshnan, A., Dunn, D., Bugg, C. W., Lo, D. C., & Patterson, P. H. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2747-08.2008 · Cited by 140
Skotte, N. H., Southwell, A. L., Østergaard, M. E., Carroll, J. B., Warby, S. C., Doty, C. N., Petoukhov, E., Vaid, K., Kordasiewicz, H., Watt, A. T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107434 · Cited by 115
Gaillard, P., Jeanclaude-Etter, I., Ardissone, V., Arkinstall, S., Cambet, Y., Camps, M., Chabert, C., Church, D. J., Cirillo, R., Gretener, D., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0310986 · Cited by 140
The intrinsically unstable life of DNA triplet repeats associated with human hereditary disorders
Bowater, R. P., & Wells, R. D. (2000) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(00)66029-4 · Cited by 139
Zinc: indications in brain disorders
Prakash, A. K., Bharti, K., & Majeed, A. B. A. (2015) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12110 · Cited by 138
Huntington Disease and the Huntingtin Protein
Zheng, Z., & Diamond, M. I. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385883-2.00010-2 · Cited by 139
Ubiquitin–proteasome system involvement in Huntington’s disease
Ortega, Z., & Lucas, J. J. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00077 · Cited by 113
Molecular medicine for the brain: silencing of disease genes with RNA interference
Davidson, B. L., & Paulson, H. L. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00678-7 · Cited by 137
Antisense Oligonucleotide Therapy: From Design to the Huntington Disease Clinic
Rook, M. E., & Southwell, A. L. (2022) · BioDrugs · doi:10.1007/s40259-022-00519-9 · Cited by 135
Hopkins, K. M., Auerbach, W., Wang, X. Y., Hande, M. P., Hang, H., Wolgemuth, D. J., Joyner, A. L., & Lieberman, H. B. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7235-7248.2004 · Cited by 113
Self-citationLombardi, M. S., Jaspers, L., Spronkmans, C., Gellera, C., Taroni, F., Maria, E. D., Donato, S. D., & Kaemmerer, W. F. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.03.004 · Cited by 134
Expression and Characterization of Full-length Human Huntingtin, an Elongated HEAT Repeat Protein
Li, W., Serpell, L. C., Carter, W. J., Rubinsztein, D. C., & Huntington, J. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511007200 · Cited by 134
Genetically modified pig models for neurodegenerative disorders
Holm, I. E., Alstrup, A. K. O., & Luo, Y. (2015) · The Journal of Pathology · doi:10.1002/path.4654 · Cited by 133
Abnormal Motor Cortex Excitability in Preclinical and Very Early Huntington's Disease
Schippling, S., Schneider, S. A., Bhatia, K., Münchau, A. M., Rothwell, J. C., Tabrizi, S. J., & Orth, M. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.12.026 · Cited by 133
Neuropathology of Huntington's Disease
Vonsattel, J. P., Keller, C. E., & Amaya, M. D. P. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01256-0 · Cited by 132
Self-citationHuntingtin in health and disease
Young, A. B. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17742 · Cited by 118
Huntington’s disease: pathogenesis to animal models
Kumar, P., Kalonia, H., & Kumar, A. (2010) · Pharmacological Reports · doi:10.1016/s1734-1140(10)70238-3 · Cited by 129
Body weight is modulated by levels of full-length Huntingtin
Raamsdonk, J. M. V., Gibson, W. T., Pearson, J., Murphy, Z., Lu, G., Leavitt, B. R., & Hayden, M. R. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl072 · Cited by 130
Iron dysregulation in Huntington's disease
Muller, M., & Leavitt, B. R. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12739 · Cited by 124
Eshraghi, M., Karunadharma, P. P., Blin, J., Shahani, N., Ricci, E. P., Michel, A. M., Urban, N. T., Galli, N., Sharma, M., Ramírez-Jarquín, U. N., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21637-y · Cited by 128
Role of NR2B-type NMDA receptors in selective neurodegeneration in Huntington disease
Li, L., Fan, M., Icton, C. D., Chen, N., Leavitt, B. R., Hayden, M. R., Murphy, T. H., & Raymond, L. A. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.04.003 · Cited by 128
Modulation of nucleosome dynamics in Huntington's disease
Stack, E. C., Del Signore, S. J., Luthi-Carter, R., Soh, B. Y., Goldstein, D. R., Matson, S., Goodrich, S., Markey, A. L., Cormier, K., Hagerty, S. W., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm064 · Cited by 120
Phosphorylation of Human Rad9 Is Required for Genotoxin-activated Checkpoint Signaling
Roos-Mattjus, P., Hopkins, K. M., Oestreich, A. J., Vroman, B. T., Johnson, K. L., Naylor, S., Lieberman, H. B., & Karnitz, L. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301544200 · Cited by 113
De Rooij, K. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.8.1093 · Cited by 113
Bilsen, P. H. J. V., Jaspers, L., Lombardi, M. S., Odekerken, J. C. E., Burright, E. N., & Kaemmerer, W. F. (2008) · Human Gene Therapy · doi:10.1089/hum.2007.116 · Cited by 114
Meade, C. A., Deng, Y., Fusco, F. R., Del Mar, N., Hersch, S., Goldowitz, D., & Reiner, A. (2002) · Journal of Comparative Neurology · doi:10.1002/cne.10295 · Cited by 111
Calcium-Handling Defects and Neurodegenerative Disease
Schrank, S., Barrington, N. M., & Stutzmann, G. E. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a035212 · Cited by 122
Popoli, P., Blum, D., Martire, A., Ledent, C. A., Ceruti, S., & Abbracchio, M. P. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.12.005 · Cited by 122
The CAG/Polyglutamine Tract Diseases: Gene Products and Molecular Pathogenesis
Koshy, B. T., & Zoghbi, H. Y. (1997) · Brain Pathology · doi:10.1111/j.1750-3639.1997.tb00894.x · Cited by 113
Multiple pathways contribute to the pathogenesis of Huntington disease.
Li, S., & Li, X. (2006) · Molecular Neurodegeneration · doi:10.1186/1750-1326-1-19 · Cited by 122
Huntingtin promotes mTORC1 signaling in the pathogenesis of Huntington’s disease
Pryor, W. M., Biagioli, M., Shahani, N., Swarnkar, S., Huang, W.-C., Page, D. T., MacDonald, M. E., & Subramaniam, S. (2014) · Science Signaling · doi:10.1126/scisignal.2005633 · Cited by 116
Self-citationBarnat, M., Friec, J. L., Benstaali, C., & Humbert, S. (2016) · Neuron · doi:10.1016/j.neuron.2016.11.035 · Cited by 120
Neurotrophic factors in Huntington's disease
Alberch, J., Pérez‐Navarro, E., & Canals, J. M. (2004) · Progress in brain research · doi:10.1016/s0079-6123(03)46014-7 · Cited by 119
McCaw, E. A., Hu, H., Gomez, G. T., Hebb, A. L. O., Kelly, M. E. M., & Denovan‐Wright, E. M. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04460.x · Cited by 119
Transgenic models of Huntington's disease
Bates, G. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.10.1633 · Cited by 108
OʼKusky, J. R., Nasir, J., Cicchetti, F., Parent, A., & Hayden, M. R. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01312-2 · Cited by 118
MacDonald, M. E., Ginés, S., Gusella, J. F., & Wheeler, V. C. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:4:1-2:7 · Cited by 117
Self-citationIsolation of a 40-kDa Huntingtin-associated Protein
Peters, M. F., & Ross, C. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008099200 · Cited by 116
Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation
Valenza, M., Carroll, J. B., Leoni, V., Bertram, L. N., Bjorkhem, I., Singaraja, R. R., Di Donato, S., Lutjohann, D., Hayden, M. R., & Cattaneo, E. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm170 · Cited by 115
Characterization of the Huntington's disease (HD) gene homolog in the zebrafish Danio rerio
Karlovich, C., John, R. M., Ramirez, L., Stainier, D. Y. R., & Myers, R. (1998) · Gene · doi:10.1016/s0378-1119(98)00342-4 · Cited by 115
Mutant Huntingtin Affects Cortical Progenitor Cell Division and Development of the Mouse Neocortex
Molina-Calavita, M., Barnat, M., Elias, S., Aparicio, E., Piel, M., & Humbert, S. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0715-14.2014 · Cited by 97
Fly models of Huntington's disease
Marsh, J. L., Pallos, J., & Thompson, L. M. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg271 · Cited by 114
Hodgson, J. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.12.1875 · Cited by 100
Autophagy and polyglutamine diseases
Jimenez-Sanchez, M., Thomson, F., Zavodszky, E., & Rubinsztein, D. C. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.013 · Cited by 103
Diekmann, H., Anichtchik, O., Fleming, A., Futter, M., Goldsmith, P., Roach, A., & Rubinsztein, D. C. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.6039-08.2009 · Cited by 87
The bZIP transcription factor LCR-F1 is essential for mesoderm formation in mouse development.
Farmer, S. C., Sun, C. W., Winnier, G. E., Hogan, B. L., & Townes, T. M. (1997) · Genes & Development · doi:10.1101/gad.11.6.786 · Cited by 107
Zhang, S., Feany, M. B., Saraswati, S., Littleton, J. T., & Perrimon, N. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.000653 · Cited by 96
Strehlow, A. N. T., Li, J. Z., & Myers, R. M. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddl467 · Cited by 92
Wild-type HTT modulates the enzymatic activity of the neuronal palmitoyl transferase HIP14
Huang, K., Sanders, S. S., Kang, R., Carroll, J. B., Sutton, L. M., Wan, J., Singaraja, R. R., Young, F. B. J., Liu, L., El-Husseini, A., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr242 · Cited by 110
Huntington Disease and the Related Disorder, Dentatorubral-Pallidoluysian Atrophy (DRPLA)
Ross, C. A., Margolis, R. L., Rosenblatt, A., Ranen, N. G., Bêcher, M. W., & Aylward, E. (1997) · Medicine · doi:10.1097/00005792-199709000-00001 · Cited by 110
Identification of NUB1 as a suppressor of mutant Huntingtin toxicity via enhanced protein clearance
Lu, B., Al‐Ramahi, I., Valencia, A., Wang, Q., Berenshteyn, F., Yang, H., Gallego‐Flores, T., Ichcho, S., Lacoste, A., Hild, M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3367 · Cited by 109
Savage, J. C., St-Pierre, M.-K., Carrier, M., El Hajj, H., Novak, S. W., Sanchez, M. G., Cicchetti, F., & Tremblay, M.-È. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01782-9 · Cited by 103
Gouw, L. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.3.525 · Cited by 104
Young, J. E., Gouw, L. G., Propp, S. S., Sopher, B. L., Taylor, J., Lin, A., Hermel, E., Logvinova, A. V., Chen, S. F., Chen, S., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705265200 · Cited by 103
Huntington Disease as a Neurodevelopmental Disorder and Early Signs of the Disease in Stem Cells
Wiatr, K., Szlachcic, W. J., Trzeciak, M., Figlerowicz, M., & Figiel, M. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0477-7 · Cited by 102
Metadata
- Authors
- Duyao, M. P., Auerbach, A. B., Ryan, A., Persichetti, F., Barnes, G. T., McNeil, S. M., Ge, P., Vonsattel, J.-P., Gusella, J. F., Joyner, A. L., & MacDonald, M. E.
- Affiliations
- Massachusetts General Hospital (US)
- Mount Sinai Hospital (CA)
- Corresponding author
- MacDonald, Marcy E.
- Venue
- Science
- Published
- 1995-07-21
- Volume
- 269
- Issue
- 5222
- Pages
- 407-410
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2002644780
- Cited by
- 723
- References
- 29
- Citations by year
- 2026: 13 · 2025: 18 · 2024: 15 · 2023: 16 · 2022: 18 · 2021: 26 · 2020: 20 · 2019: 22 · 2018: 20 · 2017: 26 · 2016: 20 · 2015: 21 · 2014: 33 · 2013: 22 · 2012: 32
- FWCI
- 12.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS 16367, NS32765, R01NS032765)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- Huntington's disease, huntingtin, gene targeting, embryonic lethality, gastrulation, loss of function, gain-of-function, CAG repeat expansion, mouse model, neurodegeneration
- MeSH terms
- Huntingtin Protein, Animals, Base Sequence, Cell Line, Ectoderm, Female, Embryonic and Fetal Development, Genotype, Heterozygote, Homozygote, Humans, Huntington Disease, Male, Mesoderm, Mice, Inbred C57BL, Molecular Sequence Data, Nerve Tissue Proteins, Nuclear Proteins, Phenotype, Stem Cells, Gene Targeting, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.